Discontinuation of Pneumocystis Jirovecii Pneumonia Prophylaxis With CD4 Count <200 Cells/µL and Virologic Suppression: A Systematic Review

PLoS ONE - United States
doi 10.1371/journal.pone.0028570
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Nonadherence to Primary Prophylaxis Against Pneumocystis Jirovecii Pneumonia

PLoS ONE
Multidisciplinary
2009English

Pneumocystis Jirovecii Pneumonia Complicating Treatment With Infliximab

The Internet Journal of Pulmonary Medicine
2006English

Pneumocystis Pneumonia: Immunosuppression, Pneumocystis Jirovecii...and the Third Man

Nature Reviews Microbiology
Infectious DiseasesImmunologyMicrobiologyMicrobiology
2007English

Safety and Efficacy of Prophylaxis for Pneumocystis Jirovecii Pneumonia Involving Trimethoprim-Sulfamethoxazole Dose Reduction in Kidney Transplantation

BMC Infectious Diseases
Infectious Diseases
2019English

Impact of Pneumocystis Jirovecii Pneumonia on Kidney Transplant Outcome

BMC Nephrology
Nephrology
2019English

Positive Pneumocystis Jirovecii Sputum PCR Results With Negative Bronchoscopic PCR Results in Suspected Pneumocystis Pneumonia

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2018English

Pneumocystis Jirovecii Pneumonia in a Patient With Breast Cancer Receiving Neoadjuvant Dose-Dense Chemotherapy

Internal Medicine
Internal MedicineMedicine
2020English

Methotrexate and Trimethoprim-Sulfamethoxazole for Pneumocystis Pneumonia Prophylaxis

Journal of Rheumatology
RheumatologyAllergyImmunology
2011English

Low Prevalence of Pneumocystis Jirovecii Lung Colonization in Ugandan HIV-infected Patients Hospitalized With Non-Pneumocystis Pneumonia

Diagnostic Microbiology and Infectious Disease
MedicineInfectious DiseasesMicrobiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy